Methylprednisolone Transdermal Patch 5mg/day from Japan
7-day transdermal patch system releasing 5mg/day methylprednisolone for chronic pain management. HTS 3004.32.00.40 explicitly includes transdermal administration systems put up for retail therapeutic use.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Adhesive skin contact study and permeation rate data required
• Packaging must protect from humidity; declare moisture barrier specs
• Monitor for controlled substance scheduling if combined with opioids